Helicobacter pylori peptidoglycan modifications confer lysozyme resistance and contribute to survival in the host

mBio

Volumn 3, Issue 6, 2012, Pages

  Wang, Ge ^a   Lo, Leja F ^a   Forsberg, Lennart S ^a   Maier, Robert J ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; LACTOFERRIN; LYSOZYME; N DEACETYLASE; PEPTIDOGLYCAN; PEPTIDOGLYCAN O ACYLTRANSFERASE; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL; BACTERIAL COLONIZATION; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME MODIFICATION; HELICOBACTER PYLORI; IN VITRO STUDY; IN VIVO STUDY; LYSOZYME RESISTANCE; LYSOZYME SENSITIVITY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PURIFICATION; SENSITIVITY ANALYSIS; ANIMAL; CHEMISTRY; DISEASE MODEL; ENZYMOLOGY; HELICOBACTER INFECTION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; VIRULENCE;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI; NEGIBACTERIA;

ACETYLTRANSFERASES; ANIMALS; DISEASE MODELS, ANIMAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; MASS SPECTROMETRY; MICE; MICROBIAL VIABILITY; MURAMIDASE; PEPTIDOGLYCAN; VIRULENCE;

EID: 84872168801     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00409-12     Document Type: Article

References (40)

1. Vollmer W. 2008. Structural variation in the glycan strands of bacterial peptidoglycan. FEMS Microbiol. Rev. 32:287-306.
2. Dziarski R. 2003. Recognition of bacterial peptidoglycan by the innate immune system. Cell. Mol. Life Sci. 60:1793-1804.
3. Cramer EM, Breton-Gorius J. 1987. Ultrastructural localization of lysozyme in human neutrophils by immunogold. J. Leukoc. Biol. 41: 242-247.
4. Callewaert L, Michiels CW. 2010. Lysozymes in the animal kingdom. J. Biosci. 35:127-160.
5. Keshav S, Chung P, Milon G, Gordon S. 1991. Lysozyme is an inducible marker of macrophage activation in murine tissues as demonstrated by in situ hybridization. J. Exp. Med. 174:1049-1058.
6. Fahlgren A, Hammarström S, Danielsson A, Hammarström ML. 2003. Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin. Exp. Immunol. 131: 90-101.
7. Davis KM, Weiser JN. 2011. Modifications to the peptidoglycan backbone help bacteria to establish infection. Infect. Immun. 79:562-570.
8. Bera A, Herbert S, Jakob A, Vollmer W, Götz F. 2005. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol. Microbiol. 55:778-787.
9. Hébert L, et al. 2007. Enterococcus faecalis constitutes an unusual bacterial model in lysozyme resistance. Infect. Immun. 75:5390-5398.
10. Vollmer W, Tomasz A. 2000. The pgdA gene encodes for a peptidoglycan N-acetylglucosamine deacetylase in Streptococcus pneumoniae. J. Biol. Chem. 275:20496-20501.
11. Meyrand M, et al. 2007. Peptidoglycan N-acetylglucosamine deacetylation decreases autolysis in Lactococcus lactis. Microbiology 153(Pt 10): 3275-3285.
12. Boneca IG, et al. 2007. A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proc. Natl. Acad. Sci. U. S. A. 104:997-1002.
13. Psylinakis E, et al. 2005. Peptidoglycan N-acetylglucosamine deacetylases from Bacillus cereus, highly conserved proteins in Bacillus anthracis. J. Biol. Chem. 280:30856-30863.
14. Dunn BE, Cohen H, Blaser MJ. 1997. Helicobacter pylori. Clin. Microbiol. Rev. 10:720-741.
15. Kusters JG, van Vliet AH, Kuipers EJ. 2006. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 19:449-490.
16. Wang G, Olczak A, Forsberg LS, Maier RJ. 2009. Oxidative stressinduced peptidoglycan deacetylase in Helicobacter pylori. J. Biol. Chem. 284:6790-6800.
17. Wang G, et al. 2010. Peptidoglycan deacetylation in Helicobacter pylori contributes to bacterial survival by mitigating host immune responses. Infect. Immun. 78:4660-4666.
18. Dillard JP, Hackett KT. 2005. Mutations affecting peptidoglycan acetylation in Neisseria gonorrhoeae and Neisseria meningitidis. Infect. Immun. 73:5697-5705.
19. Weadge JT, Pfeffer JM, Clarke AJ. 2005. Identification of a new family of enzymes with potential O-acetylpeptidoglycan esterase activity in both Gram-positive and gram-negative bacteria. BMC Microbiol. 5:49.
20. Ellison RT, Giehl TJ. 1991. Killing of gram-negative bacteria by lactoferrin and lysozyme. J. Clin. Invest. 88:1080-1091.
21. Tomb JF, et al. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539-547.
22. Moynihan PJ, Clarke AJ. 2010. O-acetylation of peptidoglycan in gramnegative bacteria: identification and characterization of peptidoglycan O-acetyltransferase in Neisseria gonorrhoeae. J. Biol. Chem. 285: 13264-13273.
23. Moynihan PJ, Clarke AJ. 2011. O-acetylated peptidoglycan: controlling the activity of bacterial autolysins and lytic enzymes of innate immune systems. Int. J. Biochem. Cell Biol. 43:1655-1659.
24. Akada JK, et al. 2003. Helicobacter pylori tissue tropism: mousecolonizing strains can target different gastric niches. Microbiology 149 19011909.
25. Wang G, Maier RJ. 2009. A RecB-like helicase in Helicobacter pylori is important for DNA repair and host colonization. Infect. Immun. 77: 286-291.
26. Costa K, et al. 1999. The morphological transition of Helicobacter pylori cells from spiral to coccoid is preceded by a substantial modification of the cell wall. J. Bacteriol. 181:3710-3715.
27. Farnaud S, Evans RW. 2003. Lactoferrin-a multifunctional protein with antimicrobial properties. Mol. Immunol. 40:395-405.
28. Deckers D, et al. 2004. Periplasmic lysozyme inhibitor contributes to lysozyme resistance in Escherichia coli. Cell. Mol. Life Sci. 61:1229-1237.
29. Callewaert L, et al. 2008. A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria. PLoS Pathog. 4:e1000019.
30. Chaput C, et al. 2006. Role of AmiA in the morphological transition of Helicobacter pylori and in immune escape. PLoS Pathog. 2:. doi: 10.1371/journal.ppat.0020097e97.
31. Chaput C, Labigne A, Boneca IG. 2007. Characterization of Helicobacter pylori lytic transglycosylases Slt and MltD. J. Bacteriol. 189:422-429.
32. Sycuro LK, et al. 2010. Peptidoglycan crosslinking relaxation promotes Helicobacter pylori's helical shape and stomach colonization. Cell 141: 822833.
33. Sycuro LK, et al. 2012. Multiple peptidoglycan modification networks modulate Helicobacter pylori's cell shape, motility, and colonization potential. PLoS Pathog. 8:e1002603.
34. Bonis M, Ecobichon C, Guadagnini S, Prévost MC, Boneca IG. 2010. A M23B family metallopeptidase of Helicobacter pylori required for cell shape, pole formation and virulence. Mol. Microbiol. 78:809-819.
35. Davis KM, Akinbi HT, Standish AJ, Weiser JN. 2008. Resistance to mucosal lysozyme compensates for the fitness deficit of peptidoglycan modifications by Streptococcus pneumoniae. PLoS Pathog. 4:e1000241.
36. Girardin SE, et al. 2003. Nod1 detects a unique muropeptide from gramnegative bacterial peptidoglycan. Science 300:1584-1587.
37. Watanabe T, et al. 2010. NOD1-mediated mucosal Host defense against Helicobacter pylori. Int. J. Inflamm. 2010:476482.
38. Viala J, et al. 2004. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5:1166-1174.
39. Kaparakis M, et al. 2010. Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell. Microbiol. 12:372-385.
40. Wang G, Hong Y, Olczak A, Maier SE, Maier RJ. 2006. Dual roles of Helicobacter pylori NapA in inducing and combating oxidative stress. Infect. Immun. 74:6839-6846.